Affymax

Affymax

closed
Innovative biopharmaceutical solutions addressing unmet medical needs in hematology and oncology. Learn more

Employees
Market cap
$2.9m
Enterprise valuation
($512k) (Public information from Sep 2024)
Palo Alto California (HQ)
Authorizing premium user...